{{Rsnum
|rsid=876347
|Chromosome=9
|position=118268751
|Orientation=plus
|GMAF=0.1951
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 51.8 | 42.0 | 6.2
| HCB | 65.0 | 33.6 | 1.5
| JPT | 82.3 | 17.7 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 80.7 | 19.3 | 0.0
| CHB | 65.0 | 33.6 | 1.5
| CHD | 51.4 | 45.0 | 3.7
| GIH | 53.5 | 41.6 | 5.0
| LWK | 97.3 | 2.7 | 0.0
| MEX | 52.6 | 35.1 | 12.3
| MKK | 98.7 | 1.3 | 0.0
| TSI | 56.9 | 38.2 | 4.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19875103
|Trait=Response to antipsychotic therapy (extrapyramidal side effects)
|Title=Genomewide Association Study of Movement-Related Adverse Antipsychotic Effects
|RiskAllele=
|Pval=0.000002
|OR=NR
|ORtxt=NR
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs876347
|overall_frequency_n=23
|overall_frequency_d=128
|overall_frequency=0.179688
|n_genomes=15
|n_genomes_annotated=0
|n_haplomes=21
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}